Gunze Limited
Gunze Limited (3002.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Gunze Limited (3002.T), covering cash flow, earnings, and balance sheets.
Gunze Limited (3002.T) Income Statement & Financial Overview
Explore comprehensive income reports for Gunze Limited 3002.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $34.20B | $35.59B | $33.95B | $33.38B |
| Cost of Revenue | $23.61B | $24.02B | $23.66B | $22.64B |
| Gross Profit | $10.59B | $11.56B | $10.28B | $10.75B |
| Gross Profit Ratio | $0.31 | $0.32 | $0.30 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $9.04B | $8.75B | $8.56B | $8.82B |
| Operating Expenses | $9.04B | $8.75B | $8.80B | $8.66B |
| Total Costs & Expenses | $32.66B | $32.78B | $32.46B | $31.30B |
| Interest Income | $16.00M | $19.00M | $23.00M | $8.00M |
| Interest Expense | $26.00M | $17.00M | $20.00M | $22.00M |
| Depreciation & Amortization | $1.81B | $1.55B | $1.73B | $1.68B |
| EBITDA | $3.33B | $4.29B | $3.72B | $4.08B |
| EBITDA Ratio | $0.10 | $0.12 | $0.11 | $0.12 |
| Operating Income | $1.54B | $2.81B | $1.48B | $2.08B |
| Operating Income Ratio | $0.05 | $0.08 | $0.04 | $0.06 |
| Other Income/Expenses (Net) | $582.00M | -$190.00M | $491.00M | $284.00M |
| Income Before Tax | $2.13B | $2.62B | $1.98B | $2.37B |
| Income Before Tax Ratio | $0.06 | $0.07 | $0.06 | $0.07 |
| Income Tax Expense | $266.00M | $1.14B | $627.00M | $726.00M |
| Net Income | $1.84B | $1.49B | $1.36B | $1.60B |
| Net Income Ratio | $0.05 | $0.04 | $0.04 | $0.05 |
| EPS | $56.23 | $44.88 | $40.63 | $47.96 |
| Diluted EPS | $56.09 | $44.76 | $40.54 | $47.88 |
| Weighted Avg Shares Outstanding | $33.10M | $16.59M | $16.69M | $16.71M |
| Weighted Avg Shares Outstanding (Diluted) | $33.18M | $16.59M | $16.69M | $16.71M |
Financial performance has remained strong, with revenue growing from $33.38B in Q1 2024 to $34.20B in Q4 2024. Gross profit continued to perform well, with margins at 31% in the latest quarter. Operating income reached $1.54B in Q4 2024, holding a steady 5% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $3.33B. Net income rose to $1.84B, keeping EPS at $56.23. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan